TuoXin Pharmaceutical (301089.SZ) plans to increase its capital by 10 million RMB to invest in JinSheng Biotechnology.

Zhtng Cijng APP Xn, To xn yoy (301089.SZ) fb gnggo, gngs jing y zyu zjn 1000 wn yun du Jings jn sn shngw kj yuxin gngs (jinchng "jn sn shngw") jnxng zngz, qzhng 22.3377 wn yun jr zhc zbn, shngy bfn jr zbn guj. Gngs y jn sn shngw qinsh "guny Jings jn sn shngw kj yuxin gngs zh zngz xiy", bnc jioy wnchng hu, gngs jing zhji chyu jn sn shngw 1.75% de gqun. Financial APP News, Tianxin Pharmaceuticals (301089.SZ) announced that the company will use its own funds of 10 million yuan to increase its investment in Jiangsu JinSan Biotechnology Co., Ltd. ("JinSan Biotech"), with 223,377 yuan being included in the registered capital and the remaining portion included in capital reserves. The company has signed an agreement with JinSan Biotech regarding the increase in capital. After the completion of this transaction, the company will directly hold a 1.75% equity stake in JinSan Biotech.